![]() Addex Therapeutics Addex Therapeutics, a development-stage biopharmaceutical company, discovers small-molecule pharmaceutical products. | ![]() IRLAB Therapeutics IRLAB Therapeutics is a biotechnology company focused on Parkinson's disease (PD). | ||
Founding Date | Founding Date 2003 | Founding Date 2002 | Founding Date 2013 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Wien, AT HQ | Locations Plan-les-Ouates, CH HQ San Francisco, US | Locations Göteborg, SE HQ |
Employees | Employees 3 | Employees 23 | Employees 30 |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) CHF30k (FY, 2025) | Revenue (est.) kr57.5m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit CHF173k (FY, 2025) | Gross profit kr62.8m (FY, 2025) |
Net income | Net income N/A | Net income (CHF6.8m) (FY, 2025) | Net income (kr110m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 34.1m | Total funding raised $ 94.7m | Total funding raised N/A |

Addex Therapeutics, a development-stage biopharmaceutical company, discovers small-molecule pharmaceutical products.
View company
IRLAB Therapeutics is a biotechnology company focused on Parkinson's disease (PD).
View company